Home/ Stocks/ GOSS

Gossamer Bio, Inc. Common Stock

GOSS XNAS

$0.33 -0.01 (-3.52%) ▼ 15-min delayed

Open

$0.34

High

$0.35

Low

$0.33

Volume

3.39M

Market Cap

$76.75M

About Gossamer Bio, Inc. Common Stock

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 162 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$13.29M	$-48,221,000	$-0.21
Q2 2025	$11.49M	$-38,273,000	$-0.17
Q1 2025	$9.89M	$-36,638,000	$-0.16
FY 2024	$114.70M	$-56,528,000	$-0.25

Related Market News

No specific coverage for GOSS yet. Check out our latest market news or earnings calendar.

Get GOSS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Gossamer Bio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.